OBJECTIVE To investigate the association of sex hormones at baseline and 1 year after a lifestyle intervention on cardiovascular (CV) risk in type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS This prospective study, following the Look AHEAD: Action for Health in Diabetes (LookAHEAD) trial, of 2,260 adults with T2D, included measurements of sex hormones and sex hormone binding globulin (SHBG). Baseline levels and 1-year changes were divided into sex-specific tertiles to assess the association with CV events (n = 488 events) and weight loss interactions. RESULTS In men, higher baseline total testosterone was associated with lower CV risk (hazard ratio HR = 0.74; 95% CI 0.56–0.97). In men with ≥7% weight loss, SHBG increases were inversely associated with CV risk (HR = 0.47; 95% CI 0.26–0.85). In men with 7% weight loss, increases in estradiol were associated with CV risk (second vs. first estradiol tertile: HR = 1.64 95% CI 1.13–2.38; third vs. first estradiol tertile: HR = 1.88 95% CI 1.29–2.73). No associations were detected in women. CONCLUSIONS In men with T2D, but not women with T2D, sex hormones were associated with CV events.
Gisinger et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: